Total Funding
89
79
Total FundingPost-IPO Equity raised
Growth Score
-8 pts
Heat Score
11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
2521
Onco-Innovations is a biotech business that develops and commercializes medicines for various cancers.
- Thomas O'Shaughnessy: Chief Executive OfficerPast Role: Healthtech Consultants, President
- Stephen Novak: Chief of Research & DevelopmentPast Role: Simbec-Orion, Director, US Business Development
About the Company
Onco-Innovations is a Canadian cancer research and therapy company that specializes in oncology. Onco's objective is to prevent and cure cancer through ground-breaking research and novel solutions. The company has obtained an exclusive worldwide license to patented technology that targets solid tumors, setting new standards in cancer therapy.
Onco's dedication to excellence and innovation propels it to create new medicines that enhance patient outcomes and provide hope in the fight against cancer.
